Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 755.05 INR -1.79% Market Closed
Market Cap: 289.1B INR
Have any thoughts about
Gland Pharma Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

20.5
Current
22.2
Median
13.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
20.5
=
Enterprise Value
261.1B INR
/
EBITDA
12.8B INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
18.5
2-Years Forward
EV/EBITDA
15.1
3-Years Forward
EV/EBITDA
13.2

See Also

Discover More